Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
The trial tested six injectable doses and three oral doses over as long as 36 weeks
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
Oral semaglutide 25 mg was associated with the same weight loss efficacy in women with obesity regardless of menopausal stage, and patients reported improvements in physical function, respectively
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
Vitiligo, affecting over 90 per cent of patients in its non-segmental form, is characterized by symmetrical white patches on both sides of the body
The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
Key secondary endpoints also demonstrated statistically significant and clinically meaningful benefits with Gazyva
Subscribe To Our Newsletter & Stay Updated
